LDOC1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.529200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.829400E-01
Normal-vs-Stage2
9.770000E-01
Normal-vs-Stage3
2.666200E-01
Normal-vs-Stage4
9.405600E-01
Stage1-vs-Stage2
1.686430E-01
Stage1-vs-Stage3
4.562500E-02
Stage1-vs-Stage4
3.715600E-01
Stage2-vs-Stage3
2.600000E-01
Stage2-vs-Stage4
9.006800E-01
Stage3-vs-Stage4
2.120800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.652400E-01
Normal-vs-AfricanAmerican
4.552000E-01
Normal-vs-Asian
7.189600E-01
Caucasian-vs-AfricanAmerican
2.413600E-01
Caucasian-vs-Asian
4.471800E-01
AfricanAmerican-vs-Asian
1.489440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.352800E-01
Normal-vs-Female
8.156000E-01
Male-vs-Female
2.219600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.456800E-01
Normal-vs-Age(41-60Yrs)
6.548600E-01
Normal-vs-Age(61-80Yrs)
9.787000E-01
Normal-vs-Age(81-100Yrs)
4.489800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.356200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.646000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.478800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.308000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.694400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.033600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.437400E-01
Normal-vs-Daily Drinker
5.389400E-01
Normal-vs-Weekly Drinker
7.763000E-01
Normal-vs-Occasional Drinker
6.800200E-01
Normal-vs-Social Drinker
7.555800E-01
Non Drinker-vs-Daily Drinker
7.961000E-01
Non Drinker-vs-Weekly Drinker
5.410500E-02
Non Drinker-vs-Occasional Drinker
5.482000E-02
Non Drinker-vs-Social Drinker
4.339600E-02
Daily Drinker-vs-Weekly Drinker
1.117230E-01
Daily Drinker-vs-Occasional Drinker
8.556200E-02
Daily Drinker-vs-Social Drinker
9.454400E-02
Weekly Drinker-vs-Occasional Drinker
6.515000E-01
Weekly Drinker-vs-Social Drinker
9.727000E-01
Occasional Drinker-vs-Social Drinker
6.600000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.143000E-01
Normal-vs-Grade 2
8.134400E-01
Normal-vs-Grade 3
8.741600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.558800E-01
Grade 1-vs-Grade 3
3.538200E-01
Grade 1-vs-Grade 4
6.143000E-01
Grade 2-vs-Grade 3
3.162600E-01
Grade 2-vs-Grade 4
8.134400E-01
Grade 3-vs-Grade 4
8.741600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.574800E-01
Normal-vs-NonDiabetic
9.757200E-01
Diabetic-vs-NonDiabetic
1.545620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.530000E-01
Normal-vs-NoPancreatitis
9.765600E-01
Pancreatitis-vs-NoPancreatitis
7.952400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.644600E-01
Normal-vs-N1
9.422600E-01
N0-vs-N1
9.861400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.986400E-01
Normal-vs-TP53-NonMutant
6.874600E-01
TP53-Mutant-vs-TP53-NonMutant
2.540000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
